Primary percutaneous coronary intervention, where available, has become the therapy of choice in myocardial reperfusion during ST-elevation myocardial infarction. However, in a significant proportion ...

Background Acute inflammatory responses during and after percutaneous coronary intervention (PCI) are associated with subsequent cardiovascular event risk, but limited data exist on acute immune cell ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved with PCI when compared to clot-busting therapy. However, not all hospitals ...

Interventional cardiology made its debut 27 years ago, when Andreas Grüntzig performed the first percutaneous transluminal coronary angioplasty in a human. Since then, rapid expansion of our knowledge ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel is unknown. The incidence of ...

Age-related physiological changes augment both the potential benefit of coronary revascularization and the risk of procedure-related adverse outcomes A broad range of antithrombin and antiplatelet ...

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...

Boston Scientific Corporation BSX on Tuesday reported positive pivotal trial data for its investigational SEISMIQ 4CE ...

There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes. However, a new study reveals that the ...